Scribe Therapeutics
Executivos
Veja o organograma con seus 14 executivos principais
Biografias mais buscadas da Scribe Therapeutics
- Benjamin Oakes, Chief Executive Officer and Director
- Behzad Aghazadeh, Director
- Vijay Pande, Director
Recentes movimentos de executivos em Scribe Therapeutics
- Maria Mirotsou, ingressou na Companhia como Vice President of Discovery Biology (Notícia publicada em 21 de dezembro de 2023).
- Aarif Khakoo, ingressou na Companhia como Chief Scientific Officer and Head of Research and Development (Notícia publicada em 21 de dezembro de 2023).
Criar um alerta
para seguir os movimentos de executivos da Scribe Therapeutics.
Biotecnologia
Scribe Therapeutics possui 2.289 concorrentes concorrentes Lonza (Suíça), Eurofins (Luxemburgo) e Adaptive Phage Therapeutics (Estados Unidos).
Popular M&A news in Biotecnologia
- Attovia Therapeutics acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 14 de maio de 2024).
- Bruker has announced the acquisition of NanoString Technologies (publicado em 13 de maio de 2024).
- Aardvark Therapeutics acaba de anunciar uma arrecadação de fundos de 85 milhões de dólares. (publicado em 12 de maio de 2024).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Scribe Therapeutics
- CRISPR technologies fuelling haematological innovations
- Press Release – Scribe Therapeutics Presents Data Demonstrating Highly Potent Gene Editing In Vivo, Including Saturated Editing of Hepatocytes in NHPs, by an Engineered XE Genome Editor; Showcases Novel Epigenetic Editing Capabilities at 2024 ASGCT Annual
- News: CRISPR Partnerships Propel Precision Medicine - CRISPR Medicine
- Press Release – Scribe Therapeutics to Present on Advances in CRISPR Genome and Epigenome Editing at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting • Scribe
- Press Release – Scribe Therapeutics to Participate in the Leerink Partners Global Biopharma Conference • Scribe
- Press Release – Scribe Therapeutics Expands In Vivo Collaboration with Sanofi to Second Target • Scribe
- Press Release – Scribe Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference • Scribe
- Press Release – Scribe Therapeutics Appoints Dr. Aarif Khakoo as Chief Scientific Officer and Head of Research and Development, and Dr. Maria Mirotsou as Vice President of Discovery Biology • Scribe
- A decade later, biotech’s CRISPR revolution is still going strong
- Press Release – Scribe Announces Collaboration with Prevail, a Wholly Owned Subsidiary of Lilly, to Accelerate In Vivo CRISPR-based Genetic Medicines for Neurological and Neuromuscular Diseases • Scribe
- View more press releases Close
Redes sociais sobre Scribe Therapeutics
- Scribe Therapeutics na Wikipedia, Google News e Yahoo Finance
- Scribe Therapeutics na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Carl Gordon 
Ligue para a Scribe Therapeutics em +1 510...
